BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹4.53 | ₹4.68 | ₹1.64 | ₹3.79 | ₹3.20 |
What is the latest Earnings Per Share (EPS) of BAL PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹4.53 |
| Mar2025 | ₹4.68 |
| Mar2024 | ₹1.64 |
| Mar2023 | ₹3.79 |
| Mar2022 | ₹3.20 |
How is Earnings Per Share (EPS) of BAL PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.53 | -3.21 | |
| Mar2025 | ₹4.68 | 185.37 | |
| Mar2024 | ₹1.64 | -56.73 | |
| Mar2023 | ₹3.79 | 18.44 | |
| Mar2022 | ₹3.20 | - | |
Compare Earnings Per Share (EPS) of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹173.4 Cr | 6.8% | 25.6% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 6.8% |
25.6% |
21.4% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses